The combination of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio with liquid biopsy biomarkers improves prognosis prediction in metastatic pancreatic cancer

SILVIA GUIL LUNAJUAN RAFAEL DE LA HABA RODRIGUEZMª AUXILIADORA GÓMEZ ESPAÑA2026-01-292026-01-29202110.3390/cancers130612102-s2.0-85102300032https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33074Cancer ResearchOncologyThe combination of neutrophil–lymphocyte ratio and platelet–lymphocyte ratio with liquid biopsy biomarkers improves prognosis prediction in metastatic pancreatic cancerresearch article